During the past decade, Oncosalud Sac; Oncología conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oncosalud Sac; Oncología" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Amgen" with 2 trials sponsored, "Celldex Therapeutics" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncosalud Sac; Oncología" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Foundation Medicine, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Oncosalud Sac; Oncología" are "Breast Cancer" (4 trials), "Chemotherapy-induced Thrombocytopenia" (2 trials), "Cancer of Unknown Primary Site" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials) and "First Line Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Oncosalud Sac; Oncología" in a lesser frequency.

Most popular intervention types in "Oncosalud Sac; Oncología" are "Drug" (14 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (5 trials), "Atezolizumab" (4 trials), "Placebo" (4 trials), "Cyclophosphamide" (3 trials) and "Ipatasertib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Oncosalud Sac; Oncología" are 14 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Oncosalud Sac; Oncología". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Oncosalud Sac; Oncología, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oncosalud Sac; Oncología, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Oncosalud Sac; Oncología has several departments that took part in Clinical trials: "Oncosalud" - 2 trials